Allergy Therapeutics plc

AGYTF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$40-$11-$25-$16
Dep. & Amort.$3$2$2$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$0-$0$0$0
Change in WC-$1-$1$2-$4
Other Non-Cash$9$2-$2$6
Operating Cash Flow-$29-$8-$21-$11
Investing Activities
PP&E Inv.-$3-$2-$2-$2
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$2$0
Investing Cash Flow-$2-$1$1-$2
Financing Activities
Debt Repay.$47$19$0-$27
Stock Issued$0$0$0$79
Stock Repurch.$0$0-$37$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$28-$1$58$38
Financing Cash Flow$20$18$20$11
Forex Effect$2$0-$0$0
Net Chg. in Cash-$10$22-$14-$1
Supplemental Information
Beg. Cash$27$0$14$15
End Cash$18$22$0$14
Free Cash Flow-$31-$9-$23-$13